Abstract
The regulation of cellular energy homeostasis within the CNS is crucial not only to neuronal survival, but to the brains function as an integrator of hormonal and neural inputs that regulate many functions, such as feeding behavior. The sensing and regulation of CNS cellular energy balance is altered in many diseases. Recent studies have suggested that fatty acid metabolism plays a significant role in regulating cellular energy balance in the brain. This hypothesis is supported by observations that the pharmacological manipulation of fatty acid metabolism alters food intake and causes weight loss. Fatty acid levels are determined by fatty acid synthase (FAS), which catalyzes the de novo synthesis of longchain fatty acids that are stored as triglycerides during energy surplus, and carnitine palmitoyltransferase-1 (CPT-1), the rate-limiting enzyme for entry of long-chain acyl-CoAs into the mitochondria for fatty acid oxidation during energy deficit. Most recently, it has been reported that pharmacological manipulation of fatty acid metabolism can also alter cellular energy balance in a stroke model, thus providing neuroprotection. While the physiological contribution of fatty acid metabolism is a hypothesis that awaits further testing, here, we review studies from a number of laboratories investigating fatty acid metabolism as a therapeutic approach for obesity and disorders of CNS energy balance such as stroke.
Keywords: Fatty acid synthase, carnitine palmitoyltransferase-1, fatty acid metabolism, obesity, hypothalamus, beta-oxidation
Central Nervous System Agents in Medicinal Chemistry
Title: Targeting Fatty Acid Metabolism in the Treatments of Obesity and Disorders of CNS Cellular Energy Balance
Volume: 6 Issue: 1
Author(s): Leslie E. Landree, Eun-Kyoung Kim, Louise D. McCullough, Francis P. Kuhajda and Gabriele V. Ronnett
Affiliation:
Keywords: Fatty acid synthase, carnitine palmitoyltransferase-1, fatty acid metabolism, obesity, hypothalamus, beta-oxidation
Abstract: The regulation of cellular energy homeostasis within the CNS is crucial not only to neuronal survival, but to the brains function as an integrator of hormonal and neural inputs that regulate many functions, such as feeding behavior. The sensing and regulation of CNS cellular energy balance is altered in many diseases. Recent studies have suggested that fatty acid metabolism plays a significant role in regulating cellular energy balance in the brain. This hypothesis is supported by observations that the pharmacological manipulation of fatty acid metabolism alters food intake and causes weight loss. Fatty acid levels are determined by fatty acid synthase (FAS), which catalyzes the de novo synthesis of longchain fatty acids that are stored as triglycerides during energy surplus, and carnitine palmitoyltransferase-1 (CPT-1), the rate-limiting enzyme for entry of long-chain acyl-CoAs into the mitochondria for fatty acid oxidation during energy deficit. Most recently, it has been reported that pharmacological manipulation of fatty acid metabolism can also alter cellular energy balance in a stroke model, thus providing neuroprotection. While the physiological contribution of fatty acid metabolism is a hypothesis that awaits further testing, here, we review studies from a number of laboratories investigating fatty acid metabolism as a therapeutic approach for obesity and disorders of CNS energy balance such as stroke.
Export Options
About this article
Cite this article as:
Landree E. Leslie, Kim Eun-Kyoung, McCullough D. Louise, Kuhajda P. Francis and Ronnett V. Gabriele, Targeting Fatty Acid Metabolism in the Treatments of Obesity and Disorders of CNS Cellular Energy Balance, Central Nervous System Agents in Medicinal Chemistry 2006; 6(1) . https://dx.doi.org/10.2174/187152406776056564
DOI https://dx.doi.org/10.2174/187152406776056564 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Brain Excitatory/Inhibitory Circuits Cross-Talking with Chromogranin A During Hypertensive and Hibernating States
Current Medicinal Chemistry Experimental Animal Models of Myocardial Damage in Regenerative Medicine Studies Involving Adult Bone Marrow Derived Stem Cells: Ethical and Methodological Implications
Cardiovascular & Hematological Disorders-Drug Targets L-Arginine in the Prevention and Treatment of Cardiovascular Disease: From Basic to Clinical Research Studies
Vascular Disease Prevention (Discontinued) Stroke in Women - Oral Contraception, Pregnancy, and Hormone Replacement Therapy
Current Vascular Pharmacology The Stroke-Induced Blood-Brain Barrier Disruption: Current Progress of Inspection Technique, Mechanism, and Therapeutic Target
Current Neuropharmacology Effects of Extracellular Matrix and Integrin Interactions on Airway Smooth Muscle Phenotype and Function: It Takes Two to Tango!
Current Respiratory Medicine Reviews The Atherosclerotic Plaque Vulnerability: Focus on the Oxidative and Endoplasmic Reticulum Stress in Orchestrating the Macrophage Apoptosis in the Formation of the Necrotic Core
Current Medicinal Chemistry Possible Consequences of Blocking Transient Receptor Potential Vanilloid 1
Current Pharmaceutical Biotechnology Anti-Selectin Therapy for the Treatment of Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application
Current Molecular Pharmacology The Effect of Acute Hypoxia on Excitability in the Heart and the L-Type Calcium Channel as a Therapeutic Target
Current Drug Discovery Technologies Heat Shock Proteins: Therapeutic Perspectives in Inflammatory Disorders
Recent Patents on Inflammation & Allergy Drug Discovery PPARs as Drug Targets to Modulate Inflammatory Responses?
Current Drug Targets - Inflammation & Allergy Effects of Tea Polyphenols and their Polymers on MAPK Signaling Pathways in Cancer Research
Mini-Reviews in Medicinal Chemistry Incremental Value of Two Dimensional Speckle Tracking Echocardiography in the Functional Assessment and Characterization of Subclinical Left Ventricular Dysfunction
Current Cardiology Reviews Angiogenic Growth Factors in the Treatment of Peripheral Arterial Disease
Current Vascular Pharmacology Effect of Leptin on Vascular Nitric Oxide and Endothelial Function
Current Hypertension Reviews Development and Engineering of Lymphatic Endothelial Cells: Clinical Implications
Current Pharmaceutical Design Psoriatic Arthritis – Review of the Immunologic, Clinic and Therapeutic Aspects of an Inflammatory Systemic Disease
Current Rheumatology Reviews AMPA Receptor Antagonists for the Treatment of Stroke
Current Drug Targets - CNS & Neurological Disorders